Abstract views: 77 / PDF downloads: 155



Algan hemostatic agent (AHA), aort, bleeding, rat


In cases of death due to trauma, failure to control bleeding is shown as one of the main reasons. Therefore, effective and rapid control of bleeding is very important in reducing traumatic death rates. Many hemostatic products are used for this purpose. Algan Hemostatic Agent (AHA) is a herbal hemostatic agent obtained from a mixture of different plants. The aim of this study was to determine the efficacy of the herbal extract Algan Hemostatic Agent (AHA) in different pharmacological forms in the abdominal aortic injury model of rats. Sixty four 5-8 weeks old male rats were randomly divided into 8 groups, each consisting of eight rats (4 groups were heparinized and 4 groups were non-heparinized). Experimental abdominal aortic hemorrhage was established and physiological saline soaked sponge was applied to the control group. AHA liquid soaked sponge, liquid and powder forms were applied to the experimental groups. Bleeding time was found to be significantly shorter in other AHA groups compared to the control group. The AHA powder form was able to control bleeding by 62.5% and 87.5% in the heparinized and non-heparinized groups, respectively, in the second application (3 minutes). In the second application, the AHA sponge formulation was able to control bleeding at 37.5% and 62.5% in the heparinized and non-heparinized groups, respectively. In the second application, the AHA liquid formulation was able to control the bleeding by 50% and 75% in the heparinized and non-heparinized groups, respectively. After three applications, bleeding was controlled in all AHA groups. Bleeding could not be controlled in the heparinized and non-heparinized control groups and the bleeding time was over 6 minutes. According to the results of this study, it has been shown that AHA is an effective hemostatic agent in bleeding control compared to the control group. Again, this study showed that the technique of creating an injury with a needle in the aortic hemorrhage model is more standardized than other methods.


Brunett, PH., Cameron, PA. (2012): Trauma in adults. In: Tintinalli, JE., Stapczynski, JS., Ma, OJ., Cline, DM., Cydulka, RK., Meckler, GD. (eds). Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 17th ed. New York, USA, McGraw Hill.

Hanks, JB., Kjaergard, HK., Hollingsbee, DA. (2003): A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 35: 439-444.

Ersoy, G., Kaynak, MF., Yilmaz, O., Rodoplu, U., Maltepe, F., Gokmen, N. (2007): Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Therapy 24: 485-492.

Ward, KR., Tiba, MH., Holbert, WH., Blocher, CR., Draucker, GT., Proffitt, EK., Bowlin, GL., Ivatury RR., Diegelmann, RF. (2007): Comparison of a new hemostatic agent to current combat hemostatic agents in a swine model of lethal extremity arterial hemorrhage. J Trauma 63: 276-283.

Beyazit, Y., Kurt, M., Kekilli, M., Goker, H., Haznedaroglu, IC. (2010): Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 15: 329-336.

Burkatovskaya, M., Tegos, GP., Swietlik, E., Demidova, TN., Castano, PA., Hamblin, MR. (2006): Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials 27: 4157-64.

Aktop, S., Emekli-Alturfan, E., Ozer, C., Gonul, O., Garip, H., Yarat, A., Goker, K. (2014): Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats. Clin Appl Thromb Hemost 20: 16-21.

Ucar, Albayrak, C., Caliskan, U., Haznedaroglu, IC., Goker, H. (2008): Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 36: 1447-1448.

Kose, R., Sogut, O., Demir, T., Koruk, I. (2012): Hemostatic efficacy of folkloric medicinal plant extract in a rat skin bleeding model. Dermatol Surg 38(5): 760-6.

Midi, A., Kumandas, A., Ekici, H., Bayraktar, F., Karapirli, K., Karahan, S., Turk, M., Ozyurek, HE. (2019): Investigation of the Efficacy of Algan Hemostatic Agent in Liver Laceration Model in Rats. EJMO 3(1): 37–42.

Abacioglu, S., Aydin, K., Buyukcam, F., Kaya, U., Isik, B., Karakilic, ME. (2016): Comparison of the Efficiencies of Buffers Containing Ankaferd and Chitosan on Hemostasis in an Experimental Rat Model with Femoral Artery Bleeding. Turk J Haematol 33(1): 48-52.

Kandemir, O., Buyukates, M., Kandemir, NO., Aktunc, E., Gul, AE., Gul, S., Turan, SA. (2010): Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model. J Cardiothorac Surg 5(1): 110-16.

Onk, OA., Aksut, M., Ozcelik, F., Onk, D., Sertoglu, E., Erol, HS., Karaman, U., Tuncer, ON., Yiginer, O., Erkut, B.(2016): Haemostatic Effects of Topical Ankaferd Blood Stopper® On Bleeding Time in A Rat Abdominal Aortic Bleeding Model. Kosuyolu Heart J 19(2): 103-107.

Yesilada, E., Sezik, E., Honda, G., Takaishi, Y., Takeda, Y., Tanaka, T. (1999): Traditional medicine in Turkey IX. Folk medicine in north-west Anatolia. J Ethnopharmacol 64(3): 195-210.

Hsieh, CL., Lin, CH., Wang, HE., Peng, CC., Peng, RY. (2015): Gallic Acid Exhibits Risks of Inducing Muscular Hemorrhagic Liposis and Cerebral Hemorrhage—Its Action Mechanism and Preventive Strategy. Phytother Res 29(2): 267-280.

Yao, C., Hao, R., Pan, S., & Wang, Y. (2012): Functional foods based on traditional Chinese medicine. In Bouayed J, ed. Nutrition Well-Being and Health Chapter 8; InTech. Europa, pp. 179-200.

Quamar, MF., Bera, SK. (2014): Ethno-medico-botanical studies of plant resources of Hoshangabad district, Madhya Pradesh, India: retrospect and prospects. J Plant Sci Res 1(1): 1-11.

Goker, H., Haznedaroglu, IC., Ercetin, S., Kirazli, S., Akman, U., Ozturk, Y., Firat, HC. (2008): Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper®. Int J Med Res 36(1): 163-170.

Colman, RW., Marder, VJ., Clowes, AW., George, JN., Goldhaber, SZ. (2005): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed., Lippincott, Williams&Wilkins, Philadelphia, pp.1-16.

Glick, JB., Kaur, RR., Siegel, D. (2013): Achieving hemostasis in dermatology Part- II. Topical hemostatic agents. Indian Dermatol Online J 4(3): 172-6.

Jackson, MR. (2001): New and potential uses of fibrin sealants as an adjunct to surgical hemostasis. Am J Surg 18: 36-39.

Chapman, WC. (2001): Costasis Multi-center Collaborative Writing Committee. A novel collagen-based composite offers effective hemostasis for multiple surgical indications: Results of a randomized controlled trial. Surgery 129: 445-450.

Waibel, KH., Haney, B., Moore, M., Whisman, B., Gomez, R. (2011): Safety of chitosan bandages in shellfish allergic patients. Mil Med 176(10): 1153-6.

Schwartz, M., Madariaga, J., Hirose, R., Shaver, TR., Sher, L., Chari, R., Colonna, JO., Heaton, N., Mirza, D., Adams, R., Rees, M., Lloyd, D. (2004): Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 139: 1148-1154.

Midi, A., Kumandaş, A., Ekici, H., Arda, S., Karahan, S., Şimşek, AK., Yesilada, E. (2018): Investigation of the effectiveness of algan hemostatic agent in renal venous bleeding model in rats. EJMI 2: 129-32.

Midi, A., Ekici, H., Kumandas, A., Durmus, O., Bodic, B., Tiryaki, M., Balik, MS., Yesilada, E. (2019): Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats. Marmara Med J 32(1): 27-32.

Midi, A., Ozyurek, HE., Karahan, S., Ekici, H., Kumandas, A., Turkmen, I., Kocabas, E., Turk, M., Demirel, OU., Yesilada, E. (2018): Investigation of efficacy of the plant based algan hemostatic agent in hepatectomy bleeding model in rats. EJMI 2: 195-201.

Ekici, H., Kumandas, A., Ozbaykus, AC., Dizdaroglu, H., Midi, A., Balik, MS., Yesilada E. (2022): Investigation of The Effectiveness of Plant Based Algan Hemostatic Agent in a Rat Model of Femoral Arterial Bleeding. Bezmialem Sci 10(1): 88-96.




How to Cite